Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Cymbalta ® (duloxetine)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk
Cymbalta® (duloxetine): Ingredients of animal origin
The Cymbalta capsules contain one ingredient that comes from an animal source. This is the gelatin, it comes from bovine material (cows).
Composition
The active ingredient is duloxetine.1
- One capsule contains either 30 mg or 60 mg of duloxetine (as hydrochloride).
The excipients of the capsule contents are:1
- Hypromellose
- Hypromellose acetate succinate
- Sucrose
- Sugar spheres
- Talc
- Titanium dioxide (E171)
- Triethyl citrate
The excipients of the Cymbalta 30 mg capsule shell are:1
- Gelatin
- Sodium lauryl sulfate
- Titanium dioxide (E171)
- Indigo carmine (E132)
- Edible green ink
Edible green ink contains:
- Black iron oxide - synthetic (E172)
- Yellow iron oxide - synthetic (E172)
- Propylene glycol
- Shellac
The excipients of the In Cymbalta 60 mg capsule shell are:1
- Gelatin
- Sodium lauryl sulfate
- Titanium dioxide (E171)
- Indigo carmine (E132)
- Yellow iron oxide (E172)
- Edible white ink
Edible white ink contains:
- Titanium dioxide (E171)
- Propylene glycol
- Shellac
- Povidone
Cymbalta is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients.1
References
1Cymbalta [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: 11 March 2024